Global pharmaceutical CDMO specializing in APIs and highly potent compounds
Dishman Carbogen Amcis is a contract development and manufacturing organization (CDMO) for active pharmaceutical ingredients (APIs) and intermediates, operating across multiple therapeutic areas including highly potent compounds and vitamin D derivatives. The hiring velocity and department mix—quality and manufacturing representing 65% of active roles—reflects scaling of manufacturing capacity and regulatory compliance operations, while concurrent SAP ECC and SuccessFactors implementations signal an organizational shift toward enterprise resource planning and workforce management consolidation.
Dishman is a public pharmaceutical services company headquartered in Ahmedabad, India, with 1,001–5,000 employees. The business provides contract manufacturing of APIs, intermediates, generics, and specialized formulations including hospital disinfectants. The company operates a global outsourcing model serving mid-to-large pharmaceutical customers across development, scale-up, and manufacturing phases. Active investments in instrumentation, validation frameworks, and IT compliance infrastructure reflect a maturing operational footprint supporting GMP-regulated manufacturing environments.
Contract manufacturing of active pharmaceutical ingredients (APIs), intermediates, generic APIs, highly potent APIs, vitamin D products, and hospital disinfectant formulations. Services span development, scale-up, and full-scale GMP manufacturing for global pharmaceutical companies.
SAP (MM module, ECC, SuccessFactors), analytical instrumentation (HPLC), industrial control systems (PLC, SCADA, Modbus, OPC, BACnet), Microsoft Project, and Google Cloud Platform.
Other companies in the same industry, closest in size